| Colin D Brown, CRNA | |
|
802 Kenyon Rd, Fort Dodge, IA 50501-5740 | |
| (515) 573-3101 | |
| Not Available |
| Full Name | Colin D Brown |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 802 Kenyon Rd, Fort Dodge, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881676237 | NPI | - | NPPES |
| 0114603 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 091364 (Iowa) | Primary |
| Entity Name | Trinity Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073594156 PECOS PAC ID: 7315858529 Enrollment ID: O20031204000921 |
News Archive
The overwhelming majority (93.8 percent) of patients undergoing computed tomography (CT) of the abdomen and pelvis (CTAP) in the emergency department (ED) setting are classified as clinically complex, according to a study in the June issue of the Journal of the American College of Radiology. Clinically complex is used to describe patients who are, based on documentation of their ED physician, much sicker than others.
Almost 50% percent of the population suffers from tooth sensitivity to cold, sweet and hot foods and liquids, according to a nationwide survey of 1,056 adults age 18—65+. Almost half of respondents had tried sensitivity toothpastes, but only about one-third of those found their experience to be positive, noted Larry Fishman, president of Majestic Drug Co., Inc.
A team of surgeons at Mount Sinai Beth Israel, led by William B. Inabnet III, MD, the Eugene W. Friedman, MD, Professor of Surgery and Chair for the Department of Surgery at MSBI and Chief of Endocrine Surgery Quality for the Mount Sinai Health System, have performed the first endoscopic transoral thyroidectomy in New York, and one of the first of its kind in the nation.
Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.
Voice analysis by a smartphone app identifies lung congestion in heart failure patients, allowing early intervention before their condition deteriorates.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colin D Brown, CRNA Po Box 310117, Fort Dodge, IA 50331-0117 Ph: (800) 303-7642 | Colin D Brown, CRNA 802 Kenyon Rd, Fort Dodge, IA 50501-5740 Ph: (515) 573-3101 |
News Archive
The overwhelming majority (93.8 percent) of patients undergoing computed tomography (CT) of the abdomen and pelvis (CTAP) in the emergency department (ED) setting are classified as clinically complex, according to a study in the June issue of the Journal of the American College of Radiology. Clinically complex is used to describe patients who are, based on documentation of their ED physician, much sicker than others.
Almost 50% percent of the population suffers from tooth sensitivity to cold, sweet and hot foods and liquids, according to a nationwide survey of 1,056 adults age 18—65+. Almost half of respondents had tried sensitivity toothpastes, but only about one-third of those found their experience to be positive, noted Larry Fishman, president of Majestic Drug Co., Inc.
A team of surgeons at Mount Sinai Beth Israel, led by William B. Inabnet III, MD, the Eugene W. Friedman, MD, Professor of Surgery and Chair for the Department of Surgery at MSBI and Chief of Endocrine Surgery Quality for the Mount Sinai Health System, have performed the first endoscopic transoral thyroidectomy in New York, and one of the first of its kind in the nation.
Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat secondary hyperparathyroidism in hemodialysis patients. The study demonstrated that single intravenous doses of 1 and 3 mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2 mcg for subsequent pivotal trials intended to establish the product's safety and efficacy in the targeted population.
Voice analysis by a smartphone app identifies lung congestion in heart failure patients, allowing early intervention before their condition deteriorates.
› Verified 3 days ago
Suzanne M Clapp, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 | |
Solveig A Lundgren, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 | |
Eric K Hage, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 Fax: 515-574-6456 | |
Jay A Honomichl, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 Fax: 515-574-6456 | |
Joni Whipple, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 | |
Andrew Doster, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 |